Pharmacy
Complex Generics: It’s Complicated The market of complex generics remains untapped, while their power [...]
Rapid Recalls: Managing FDA Recalls How alert systems & hospital processes are helping to better [...]
An Ideal Pharmaceutical Supply Chain: Quality Comes First HealthTrust evaluates pharmaceutical supply chains for mission-critical drugs to identify [...]
HealthTrust’s SIMS Contracting Strategy Addresses Drug Shortages The market for generic injectables continues to be plagued by [...]
Pharmacy Departments Prepare for New & Revised Compounding Standards Pharmacy leaders have had more than three years to prepare [...]
Pain Management, a Balanced Technique Older Analgesics in Combination Outmatch Expensive, New Non-Opioid Alternatives In [...]
HealthTrust Introduces Supply Interruption Mitigation Strategies Drug shortages and pricing instability on generic injectables continue to [...]
Removing the Barriers for Biosimilars Despite a Slow Start in Gaining Market Access & Share, [...]
Compounding Safety 3 Things to Know About 503B Outsourcing Facilities In the [...]
FDA Update: The Road to Approval Understanding the FDA’s Clinical Investigation Process When a healthcare facility [...]
Battling Influenza With Leading-edge Vaccines Influenza is one of the world’s most [...]
Cost Savings & Clinical Advances for Ardent Health Services’ Pharmacy Group Based in Nashville, Tennessee, Ardent Health Services operates 31 hospitals [...]
Care Across Distance The Benefits & Potential Drawbacks of Telepharmacy Services When telepharmacy [...]
Controlling Controlled Substances 4 Ways to Use Technology to Fight Opioid Diversion The [...]
Pharmaceutical Compounding How to Meet Guidelines for Sterile Prep & Safe Handling [...]
Antimicrobial Stewardship Goes Mainstream In July 2016, the Food and Drug Administration (FDA) issued [...]
A Step Beyond HealthTrust Residency Program Prepares Pharmacy Leaders for the Future “The [...]
The 340B Drug Pricing Program Pharmacy Leaders Face Reimbursement and Compliance Challenges The 340B Drug [...]
